|
US3666767A
(en)
|
1970-01-28 |
1972-05-30 |
Warner Lambert Co |
2-amino-1-(2-imidazolin-2-yl)-2-imidazolines
|
|
US4863919A
(en)
|
1988-02-01 |
1989-09-05 |
A. H. Robins Company, Incorporated |
Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
TW300219B
(enExample)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
|
JP2553020B2
(ja)
|
1991-11-07 |
1996-11-13 |
吉富製薬株式会社 |
キヌクリジン化合物およびその医薬用途
|
|
FR2730995B1
(fr)
|
1995-02-23 |
1997-04-04 |
Cird Galderma |
Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
|
US6225310B1
(en)
|
1996-01-17 |
2001-05-01 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
|
US7214686B2
(en)
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
|
US6624173B1
(en)
|
1997-06-30 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions for treating and/or preventing CNS disorders
|
|
US6462036B1
(en)
|
1998-11-06 |
2002-10-08 |
Basf Aktiengesellschaft |
Tricyclic pyrazole derivatives
|
|
US6953855B2
(en)
*
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
US6727070B2
(en)
|
2000-02-14 |
2004-04-27 |
The Board Of Regents, The University Of Texas System |
Protein/solubility folding assessed by structural complementation
|
|
AU2001241056A1
(en)
|
2000-03-09 |
2001-09-17 |
Mitsubishi Pharma Corporation |
Spiro compounds, process for preparing the same and use thereof as drugs
|
|
AU2001265840A1
(en)
|
2000-06-26 |
2002-01-08 |
Novo-Nordisk A/S |
Use of potassium channel agonists for reducing fat food comsumption
|
|
PE20021019A1
(es)
*
|
2001-04-19 |
2002-11-13 |
Upjohn Co |
Grupos azabiciclicos sustituidos
|
|
AR036041A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
|
EP1432707B1
(en)
|
2001-10-02 |
2012-03-28 |
Pharmacia & Upjohn Company LLC |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
JP2005536448A
(ja)
|
2001-11-19 |
2005-12-02 |
ファルマシア アンド アップジョン カンパニー |
アミン１，２−及び１，３−ジオール化合物、及びアルツハイマー病を治療するためのその使用
|
|
US20030109519A1
(en)
|
2001-11-30 |
2003-06-12 |
Jeppe Sturis |
Use of selective potassium channel openers
|
|
US20030125323A1
(en)
|
2001-11-30 |
2003-07-03 |
Jeppe Sturis |
Use of selective potassium channel openers
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
US20040192594A1
(en)
|
2002-01-28 |
2004-09-30 |
Paul Reid |
Modified neurotoxins as therapeutic agents for the treatment of diseases and methods of making
|
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
|
ATE447404T1
(de)
|
2002-03-29 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
|
US20030235583A1
(en)
|
2002-06-14 |
2003-12-25 |
Jeppe Sturis |
Combined use of a modulator of CD3 and a beta cell resting compound
|
|
MXPA05000754A
(es)
|
2002-07-17 |
2005-04-19 |
Warner Lambert Co |
Combinacion de un inhibidor carboxilico alosterico de la metaloproteinasa de matriz-13 con celecoxib o valdecoxib.
|
|
DE10234424A1
(de)
|
2002-07-29 |
2004-02-12 |
Bayer Ag |
Benzothiophen-, Benzofuran- und Indolharnstoffe
|
|
US7176198B2
(en)
|
2002-08-01 |
2007-02-13 |
Pfizer Inc. |
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
|
|
JP2006503008A
(ja)
|
2002-08-13 |
2006-01-26 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
マトリクスメタロプロテイナーゼ阻害物質としての４−ヒドロキシキノリン誘導体
|
|
WO2004014909A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
|
|
MXPA05001702A
(es)
|
2002-08-14 |
2005-04-19 |
Neurosearch As |
Derivados de quinuclidina novedosos y su uso.
|
|
KR101166745B1
(ko)
|
2002-09-05 |
2012-07-23 |
아방티 파르마 소시에테 아노님 |
의약으로서의 신규한 아미노인다졸 유도체 및 이를 함유하는 약제학적 조성물
|
|
WO2004039366A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
|
|
CA2503786A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases
|
|
WO2004052348A2
(en)
*
|
2002-12-11 |
2004-06-24 |
Pharmacia & Upjohn Company Llc |
Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
|
|
PL376789A1
(pl)
|
2002-12-12 |
2006-01-09 |
Aventis Pharma S.A. |
Pochodne aminoindazoli i ich zastosowanie jako inhibitorów kinazy
|
|
CA2542232A1
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals, Inc. |
Method for treating neurodegenerative disease by inhibiting alpha-synuclein
|
|
WO2005016923A1
(en)
|
2003-08-13 |
2005-02-24 |
Neurosearch A/S |
Novel quinuclidine derivatives and their pharmaceutical use
|
|
JP4755991B2
(ja)
|
2003-10-16 |
2011-08-24 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
Ｒａｆキナーゼインヒビターとしての置換ベンゾアゾールおよびその使用
|
|
US7241773B2
(en)
|
2003-12-22 |
2007-07-10 |
Abbott Laboratories |
3-quinuclidinyl heteroatom bridged biaryl derivatives
|
|
US20050239853A1
(en)
|
2004-02-04 |
2005-10-27 |
Tjeerd Barf |
New compounds
|
|
EP1713809B1
(en)
|
2004-02-04 |
2009-07-29 |
Neurosearch A/S |
Dimeric azacyclic compounds and their use
|
|
RU2417225C2
(ru)
|
2004-03-25 |
2011-04-27 |
Мемори Фармасьютиклз Корпорейшн |
Индазолы, бензотиазолы, бензоизотиазолы, бензизоксазолы и их получение и применение
|
|
JP2007534692A
(ja)
|
2004-04-22 |
2007-11-29 |
メモリー・ファーマシューティカルズ・コーポレイション |
インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
|
|
JP2007538046A
(ja)
|
2004-05-19 |
2007-12-27 |
ノイロサーチ アクティーゼルスカブ |
新規なアザビシクロアリール誘導体
|
|
US8686011B2
(en)
|
2004-05-24 |
2014-04-01 |
Amgen Inc. |
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
|
|
CN1964956B
(zh)
|
2004-05-24 |
2013-03-27 |
安美基公司 |
11-β-羟基类固醇脱氢酶1型的抑制剂
|
|
GB0415746D0
(en)
*
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
|
US7652010B2
(en)
|
2004-10-15 |
2010-01-26 |
Neurosearch A/S |
Azabicyclic aryl derivatives and their medical use
|
|
US20070082350A1
(en)
|
2005-02-09 |
2007-04-12 |
Philip Landfield |
Assay and method for diagnosing and treating alzheimer's disease
|
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
|
US7897766B2
(en)
|
2005-09-23 |
2011-03-01 |
Abbott Laboratories |
Amino-aza-adamantane derivatives and methods of use
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
PE20070823A1
(es)
|
2005-11-15 |
2007-08-09 |
Glaxo Group Ltd |
Sal tosilato de 8-(2,6-difluorofenil)-4-(4-fluoro-2-metilfenil)-2-{[2-hidroxi-1-(hidroximetil)etil]amino}pirido[2,3-]pirimidin-7(8h)-ona
|
|
EP1951696A2
(en)
|
2005-11-22 |
2008-08-06 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
TW200734338A
(en)
|
2006-01-16 |
2007-09-16 |
Organon Nv |
6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
|
|
US7687515B2
(en)
|
2006-01-17 |
2010-03-30 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
RS52062B
(sr)
|
2006-05-19 |
2012-06-30 |
Abbott Laboratories |
Cns aktivni azabiciklični alkanski derivati koji su supstituisani spojenim bicikloheterociklom
|
|
EP2038278A2
(en)
|
2006-06-27 |
2009-03-25 |
Abbott Laboratories |
Thiazoline and oxazoline derivatives and their methods of use
|
|
US7741364B2
(en)
|
2006-06-27 |
2010-06-22 |
Abbott Laboratories |
Pyrrole derivatives and their methods of use
|
|
ITMI20061279A1
(it)
|
2006-06-30 |
2008-01-01 |
Consiglio Nazionale Ricerche |
Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
|
CL2008000597A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 6-(3-ciclobutil-2,3,4,5-tetrahidro-1h-benzo[d]azepin-7-il oxi)-n-metil nicotinamida, un estabilizante y un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
|
CL2008000596A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
|
WO2008118742A1
(en)
|
2007-03-23 |
2008-10-02 |
Abbott Laboratories |
Azaadamantane ester and carbamate derivatives and methods of use thereof
|
|
MX2009010175A
(es)
|
2007-03-23 |
2009-10-12 |
Abbott Lab |
Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
|
|
EP2505588B1
(en)
|
2007-03-23 |
2013-11-13 |
AbbVie Inc. |
process for preparing AMINOMETHYL AZAADAMANTANE DERIVATIVES as SELECTIVE MODULATORS OF THE ALPHA7- NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR (NNRS)
|
|
MX2009010176A
(es)
|
2007-03-23 |
2009-10-12 |
Abbott Lab |
Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
|
|
WO2009017454A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New therapeutic combination of a gsk3 inhibitor and an a7-nicotinic agonist 960
|
|
US20090170869A1
(en)
|
2007-09-06 |
2009-07-02 |
Desmond John Best |
Piperazine derivative having affinity for the histamine h3 receptor
|
|
US20100298289A1
(en)
|
2007-10-09 |
2010-11-25 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
|
US20090099099A1
(en)
|
2007-10-16 |
2009-04-16 |
Hong Wang |
Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
US7902222B2
(en)
|
2007-11-21 |
2011-03-08 |
Abbott Laboratories |
Biaryl substituted azabicyclic alkane derivatives
|
|
CN101918409A
(zh)
|
2007-11-21 |
2010-12-15 |
雅培制药有限公司 |
联芳基取代的二氮杂双环烷衍生物
|
|
JP5498392B2
(ja)
|
2007-11-30 |
2014-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｃｎｓ障害の治療のためのｐｄｅ９ａモジュレーターとしてのそれらの使用
|
|
US8383657B2
(en)
|
2007-12-21 |
2013-02-26 |
Abbott Laboratories |
Thiazolylidine urea and amide derivatives and methods of use thereof
|
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0907492A2
(pt)
|
2008-02-07 |
2017-06-13 |
Abbott Lab |
derivados amida como moduladores alostéricos positivos e métodos de sua utilização
|
|
US7786171B2
(en)
|
2008-04-04 |
2010-08-31 |
Abbott Laboratories |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
|
US8546410B2
(en)
|
2008-05-05 |
2013-10-01 |
Abbvie Inc. |
Heteroaryl-fused macrocyclic pyrimidine derivatives
|
|
EP2328587A1
(en)
|
2008-08-29 |
2011-06-08 |
Glaxo Group Limited |
Dosage form comprising 1-isopropyl-4-{ [4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine or a salt thereof
|
|
CN102209540A
(zh)
|
2008-11-11 |
2011-10-05 |
塔加西普特公司 |
使用α7-选择性配体的治疗方法
|
|
KR20120044978A
(ko)
|
2009-06-19 |
2012-05-08 |
아보트 러보러터리즈 |
디아자호모아다만탄 유도체 및 이들의 사용 방법
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
JO3250B1
(ar)
|
2009-09-22 |
2018-09-16 |
Novartis Ag |
إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
|
|
SG179120A1
(en)
|
2009-09-29 |
2012-05-30 |
Glaxo Group Ltd |
Novel compounds
|
|
KR20120100913A
(ko)
|
2009-10-13 |
2012-09-12 |
엠에스데 오쓰 베.베. |
아세틸콜린 수용체에 관련된 질환의 치료를 위한 축합 아진 - 유도체
|
|
US8278320B2
(en)
|
2009-10-28 |
2012-10-02 |
Bristol-Myers Squibb Company |
Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
EP2493894B1
(en)
|
2009-10-28 |
2014-01-29 |
Bristol-Myers Squibb Company |
Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
AU2011218190A1
(en)
|
2010-02-17 |
2012-09-06 |
Janssen Pharmaceutica Nv |
Aminothiazolones as estrogen related receptor-alpha modulators
|
|
TWI510241B
(zh)
|
2010-02-18 |
2015-12-01 |
Vtv Therapeutice Llc |
苯基－雜芳基衍生物及其使用方法
|
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
CN103025744A
(zh)
|
2010-04-30 |
2013-04-03 |
百时美施贵宝公司 |
作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物
|
|
EP2611772B1
(en)
|
2010-09-02 |
2014-09-24 |
GlaxoSmithKline Intellectual Property Development Limited |
2-(benzyloxy)benzamides as lrrk2 kinase inhibitors
|
|
US9464078B2
(en)
|
2010-09-23 |
2016-10-11 |
Abbvie Inc. |
Monohydrate of azaadamantane derivatives
|
|
FR2966827B1
(fr)
|
2010-10-27 |
2014-08-22 |
Kimonella Ventures Ltd |
Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
|
|
EP2640378A4
(en)
|
2010-11-18 |
2014-05-21 |
Envivo Pharmaceuticals Inc |
INFLAMMATION TREATMENT WITH CERTAIN NICOTINIC ACID ALPHA-7 RECEPTOR AGONISTS IN COMBINATION WITH ACETYLCHOLINESTERASE INHIBITORS
|
|
CA2825519A1
(en)
|
2011-02-03 |
2012-09-08 |
Lupin Limited |
Pyrrole derivatives used as modulators of alpha7 nachr
|
|
JP2014076948A
(ja)
|
2011-02-09 |
2014-05-01 |
Astellas Pharma Inc |
イソキノリンアミド誘導体
|
|
RS55433B1
(sr)
|
2011-02-23 |
2017-04-28 |
Lupin Ltd |
Derivati heteroarila kao modulatori nachr alfa7
|
|
AU2012235779B2
(en)
|
2011-03-31 |
2017-03-02 |
Lupin Limited |
Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as Alzheimer's and Parkinson's disease
|
|
US8946432B2
(en)
|
2011-07-05 |
2015-02-03 |
Lupin Limited |
Biaryl derivatives as nAChR modulators
|
|
NZ629453A
(en)
|
2012-03-06 |
2016-04-29 |
Lupin Ltd |
Thiazole derivatives as alpha 7 nachr modulators
|
|
CA2873984A1
(en)
|
2012-05-23 |
2013-11-28 |
Stemergie Biotechnology Sa |
Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
|
|
EP2855471B1
(en)
|
2012-05-24 |
2017-11-15 |
Bristol-Myers Squibb Company |
QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
|
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
|
EP2945936A1
(en)
|
2012-11-12 |
2015-11-25 |
Lupin Limited |
Thiazole derivatives as alpha 7 nachr modulators
|
|
WO2014083003A1
(en)
|
2012-11-27 |
2014-06-05 |
Shire International Gmbh |
Pro-cognitive compound
|
|
KR20180014854A
(ko)
|
2012-12-11 |
2018-02-09 |
노파르티스 아게 |
알파 7 니코틴성 아세틸콜린 수용체 활성화제 치료에 대한 반응성의 예측 바이오마커
|
|
EP2945941B1
(en)
|
2013-01-16 |
2016-12-07 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nachr modulators
|
|
HUE043059T2
(hu)
|
2013-02-27 |
2019-07-29 |
Mochida Pharm Co Ltd |
Új pirazolszármazék
|
|
US9617210B2
(en)
|
2013-03-13 |
2017-04-11 |
Lupin Limited |
Pyrrole derivatives as alpha 7 NACHR modulators
|
|
TW201446243A
(zh)
|
2013-06-03 |
2014-12-16 |
Lupin Ltd |
4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
|
|
WO2014203150A1
(en)
|
2013-06-17 |
2014-12-24 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nachr modulators
|
|
WO2015066371A1
(en)
|
2013-10-31 |
2015-05-07 |
Forum Pharmaceuticals, Inc. |
SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
EP3623371A1
(en)
|
2014-12-16 |
2020-03-18 |
Axovant Sciences GmbH |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|